Angela Genge, MD, FRCP(C)

Dr. Angela Genge has been the Director of the Amyotrophic Lateral Sclerosis (ALS) clinic at The Neuro (Montreal Neurological Institute-Hospital) since 1998 and the Executive Director of the ALS Global Center of Excellence in Patient Care since 2014.

From 2004 to 2023, she was also the Executive Director of The Neuro’s Clinical Research Unit (CRU). Under her direction, the CRU grew to become one of the largest neurological clinical research centres in Canada, home to a first-of-its-kind Phase 1 Unit dedicated to neurological diseases.

She is an international leader in clinical trial design and development for rare neurological conditions with an emphasis on ALS and motor neuron disease (MND). She sits on a number of advisory boards as well as data and safety monitoring boards.